(Q43855361)

27 November 2017

title

Usefulness of Orlistat in the treatment of severe hypertriglyceridemia (English)

1 reference

27 November 2017

1

Anthony S Wierzbicki

1 reference

27 November 2017

Timothy M Reynolds

2

1 reference

27 November 2017

Martin A Crook

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

American Journal of Cardiology

27 November 2017

published in

1 reference

27 November 2017

volume

89

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

229-231

1 reference

Familial hyperchylomicronaemia

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902208-1

Orlistat, a new lipase inhibitor for the management of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902208-1

Chylomicron synthesis by intestinal cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902208-1

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902208-1

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902208-1

10.1016/S0002-9149(01)02208-1

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference